Schedule 13D ownership disclosure

Lucid Diagnostics Inc

Common Stock, par value $0.001 per share · CUSIP: 54948X109

Event date: 2026-02-03

Filing-level shares
38,816,903.00
Percent of class
27.5%
  • PAVmed Inc.Reported CIK 0001624326

    Shares: 38,816,903.00 · Class: 27.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001094891-26-000053
Form type
SCHEDULE 13D/A
Filer
Lucid Diagnostics Inc.
CIK
CIK 1799011
Filed
Feb 09, 2026
Reporting period
Feb 03, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub